Vivesto

Vivesto PEG

The PEG Ratio (Price/Earnings-to-Growth) of Vivesto (VIVE.ST) as of Oct 10, 2026 is -5.65. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was -1.71 — a change of 230.64% (lower).

PEG

-5.65

YoY

230.64%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Vivesto is 2025 -5.65 . PEG Ratio (Price/Earnings-to-Growth) of Vivesto was 2024 -1.71 . It decreases by 230.64% lower compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

PEG Ratio (Price/Earnings-to-Growth) of Vivesto is -5.65 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Vivesto changed from -1.71 to -5.65, representing a 230.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Vivesto since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Vivesto with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vivesto

All Key Metrics — Vivesto